Publications
- Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes2010 | First Faculty of Medicine
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | First Faculty of Medicine
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | First Faculty of Medicine
- Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases2011 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | Publication without faculty affiliation
- Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes2010 | Publication without faculty affiliation
- Commentary [to article Peptic ulcus disease]2008 | First Faculty of Medicine
- CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patiens after ileal resection2008 | First Faculty of Medicine
- Calprotectin Levels in Patients with Inflammatory Bowel Disease - Comparison of Two Commercial Tests2008 | First Faculty of Medicine
Loading network view...